| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $72.3M | +153.5% |
| R&D Expense | $64.8M | +15.9% |
| SG&A Expense | $19.6M | +8.9% |
| Operating Income | -$12.1M | +73.3% |
| Pre-tax Income | -$6.1M | +84.6% |
| Income Tax | $0 | -100.0% |
| Net Income | -$6.1M | +84.8% |
| EPS (Basic) | -$0.55 | +91.8% |
| EPS (Diluted) | -$0.55 | +91.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.5M | +52.4% |
| Accounts Receivable | $974K | — |
| Current Assets | $254.5M | +120.4% |
| Total Assets | $257.6M | +116.2% |
| Current Liabilities | $48.8M | +2.0% |
| Total Liabilities | $50.8M | -40.8% |
| Stockholders' Equity | $206.8M | +519.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.1M | +19.6% |
| Capital Expenditures | $66K | +135.7% |
| Investing Cash Flow | -$113.5M | -382.5% |
| Financing Cash Flow | $174.7M | +493.1% |
| Free Cash Flow | -$41.2M | +19.5% |